The latest closing stock price for Spyre Therapeutics as of November 08, 2024 is 39.58.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-838 today, roughly -1 times their original investment - a -18.31% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 47.97, which is 21.2% above the current share price.
The Spyre Therapeutics 52-week low stock price is 8.75, which is 77.9% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 28.52.
An investor who bought $1,000 worth of Spyre Therapeutics stock at the IPO in 2016 would have $-838 today, roughly -1 times their original investment - a -18.31% compound annual growth rate over 9 years.
The all-time high Spyre Therapeutics stock closing price was 299.75 on April 08, 2016.
The Spyre Therapeutics 52-week high stock price is 47.97, which is 21.2% above the current share price.
The Spyre Therapeutics 52-week low stock price is 8.75, which is 77.9% below the current share price.
The average Spyre Therapeutics stock price for the last 52 weeks is 28.52.